Ignite Creation Date:
2024-05-06 @ 8:10 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06285877
Status:
RECRUITING
Last Update Posted:
2024-02-29
First Post:
2024-01-30
Brief Title:
Effectiveness of the Use of the Nintendo Switch Combined With Conventional Therapy in People With Acquired Brain Injury
Sponsor:
Universidad Rey Juan Carlos
Organization:
Universidad Rey Juan Carlos
Study Overview
Official Title:
Study on the Effectiveness of the Use of the Nintendo Switch Combined With Conventional Therapy in People With Acquired Brain Injury A Pilot Study
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Purpose to observe the possible benefits produced by conventional therapy through virtual reality with the Nintendo Switch to try to improve motivation and increase the degree of care satisfaction The aim is to improve postural control in both seated and standing positions and to maintain and improve cognitive capacity
Material and methods one group experimental group will receive a total of 8 one-hour sessions or 16 half-hour sessions depending on their individual needs for 8 weeks using the Nintendo Switch The other group control group will continue to receive their conventional scheduled therapy
Measures Abilhand MEC-Lobo FIST Fugl-Meyer Berg Balance Scale and CSQ-8
Material and methods one group experimental group will receive a total of 8 one-hour sessions or 16 half-hour sessions depending on their individual needs for 8 weeks using the Nintendo Switch The other group control group will continue to receive their conventional scheduled therapy
Measures Abilhand MEC-Lobo FIST Fugl-Meyer Berg Balance Scale and CSQ-8
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None